loadpatents
name:-0.018336057662964
name:-0.0089240074157715
name:-0.016496896743774
Atkins; Annette Patent Filings

Atkins; Annette

Patent Applications and Registrations

Patent applications and USPTO patent grants for Atkins; Annette.The latest application filed is for "compositions and methods for organoid generation and disease modeling".

Company Profile
14.8.27
  • Atkins; Annette - San Diego CA
  • ATKINS; Annette - La Jolla CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Analogs of fexaramine and methods of making and using
Grant 11,440,889 - Evans , et al. September 13, 2
2022-09-13
Compositions And Methods For Organoid Generation And Disease Modeling
App 20220220446 - EVANS; Ronald ;   et al.
2022-07-14
Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment
Grant 11,376,264 - Evans , et al. July 5, 2
2022-07-05
Cells, Islets, And Organoids That Evade Immune Detection And Autoimmunity, Methods Of Production And Use Thereof
App 20210363490 - YOSHIHARA; Eiji ;   et al.
2021-11-25
Analogs Of Fexaramine And Methods Of Making And Using
App 20210147365 - Evans; Ronald M. ;   et al.
2021-05-20
Fibroblast Growth Factor 1 (fgf1) Mutant Proteins That Selectively Activate Fgfr1b To Reduce Blood Glucose
App 20210032303 - Evans; Ronald M. ;   et al.
2021-02-04
Analogs of fexaramine and methods of making and using
Grant 10,815,203 - Evans , et al. October 27, 2
2020-10-27
Treatment of steroid-induced hyperglycemia with fibroblast growth factor (FGF) 1 analogs
Grant 10,695,404 - Evans , et al.
2020-06-30
Use Of Bromodomain-containing Protein 9 Antagonists In Combination With Vitamin D Receptor Agonists In Diabetes Treatment
App 20200129532 - Evans; Ronald M. ;   et al.
2020-04-30
Analogs Of Fexaramine And Methods Of Making And Using
App 20200123113 - Evans; Ronald M. ;   et al.
2020-04-23
Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods Of Use To Reduce Blood Glucose
App 20200040051 - Evans; Ronald M. ;   et al.
2020-02-06
Analogs of fexaramine and methods of making and using
Grant 10,450,277 - Evans , et al. Oc
2019-10-22
Use Of Fibroblast Growth Factor 1 (fgf1)-vagus Nerve Targeting Chimeric Proteins To Treat Hyperglycemia
App 20190276510 - Evans; Ronald M. ;   et al.
2019-09-12
Compositions And Methods For Organoid Generation And Disease Modeling
App 20190211310 - EVANS; RONALD ;   et al.
2019-07-11
Mutated Fibroblast Growth Factor (fgf) 1 And Methods Of Use
App 20190192630 - Suh; Jae Myoung ;   et al.
2019-06-27
Analogs of fexaramine and methods of making and using
Grant 10,301,268 - Evans , et al.
2019-05-28
Fibroblast Growth Factor (fgf) 1 Proteins With Glucose Lowering Ability And Reduced Mitogenicity
App 20190151416 - Evans; Ronald M. ;   et al.
2019-05-23
Analogs Of Fexaramine And Methods Of Making And Using
App 20190084939 - Evans; Ronald M. ;   et al.
2019-03-21
Fgf2 Truncations And Mutants And Uses Thereof
App 20180319857 - Evans; Ronald M. ;   et al.
2018-11-08
Treatment Of Steroid-induced Hyperglycemia With Fibroblast Growth Factor (fgf) 1 Analogs
App 20180228869 - Evans; Ronald M. ;   et al.
2018-08-16
ESTROGEN RELATED RECEPTOR GAMMA (ERRgamma) ENHANCES AND MAINTAINS BROWN FAT THERMOGENIC CAPACITY
App 20180207114 - Evans; Ronald M. ;   et al.
2018-07-26
Mutated Fibroblast Growth Factor (fgf) 1 And Methods Of Use
App 20180193418 - Suh; Jae Myoung ;   et al.
2018-07-12
Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use
Grant 9,925,243 - Suh , et al. March 27, 2
2018-03-27
Mutated fibroblast growth factor (FGF) 1 and methods of use
Grant 9,925,241 - Suh , et al. March 27, 2
2018-03-27
Fibroblast Growth Factor (fgf) 1 Mutants And Methods Of Use To Reduce Blood Glucose
App 20180057554 - Evans; Ronald M. ;   et al.
2018-03-01
Err Alpha And Err Gamma Are Essential Coordinators Of Cardiac Metabolism And Function
App 20180015057 - Evans; Ronald M. ;   et al.
2018-01-18
Intestinal Fxr Agonism Enhances Glp-1 Signaling To Restore Pancreatic Beta Cell Functions
App 20180000768 - Fang; Sungsoon ;   et al.
2018-01-04
Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods Of Use To Reduce Blood Glucose
App 20170355739 - Evans; Ronald M. ;   et al.
2017-12-14
Methods Of Using Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods To Reduce Blood Glucose
App 20170355740 - Evans; Ronald M. ;   et al.
2017-12-14
Fgf2 Truncations And Mutants And Uses Thereof
App 20170291931 - Evans; Ronald M. ;   et al.
2017-10-12
Analogs Of Fexaramine And Methods Of Making And Using
App 20170066724 - Evans; Ronald M. ;   et al.
2017-03-09
Chimeric Fibroblast Growth Factor (fgf) 2/fgf1 Peptides And Methods Of Use
App 20160237133 - Suh; Jae Myoung ;   et al.
2016-08-18
Chimeric Fibroblast Growth Factor (fgf) 2/fgf1 Peptides And Methods Of Use
App 20160206695 - Suh; Jae Myoung ;   et al.
2016-07-21
Methods Of Using Fexaramine And Agents That Increase Sympathetic Nervous System Activity To Promote Browning Of White Adipose Tissue
App 20150258052 - Evans; Ronald M. ;   et al.
2015-09-17
Mutated Fibroblast Growth Factor (fgf) 1 And Methods Of Use
App 20150111821 - Suh; Jae Myoung ;   et al.
2015-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed